Nano Delivery System for Atherosclerosis
Atherosclerosis, a pathological process propelled by inflammatory mediators and lipids, is a principal contributor to cardiovascular disease incidents. Currently, drug therapy, the primary therapeutic strategy for atherosclerosis, faces challenges such as poor stability and significant side effects....
Saved in:
Main Authors: | Zhuoyi Rong, Xuan He, Tianjian Fan, Haitao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Journal of Functional Biomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4983/16/1/2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronary plaque characteristics quantified by artificial intelligence-enabled plaque analysis: Insights from a multi-ethnic asymptomatic US population
by: Guadalupe Flores Tomasino, et al.
Published: (2025-03-01) -
A minimally invasive animal model of atherosclerosis and neointimal hyperplasia for translational research
by: Max L. A. Ebert, et al.
Published: (2025-02-01) -
TEAD1‐Mediated Trans‐Differentiation of Vascular Smooth Muscle Cells into Fibroblast‐Like Cells Contributes to the Stabilization and Repair of Disrupted Atherosclerotic Plaques
by: Ming Zhai, et al.
Published: (2025-02-01) -
Nano theranostics involved in bladder cancer treatment
by: Kunpeng Liu, et al.
Published: (2023-04-01) -
FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages
by: Qiang Gu, et al.
Published: (2025-02-01)